127 related articles for article (PubMed ID: 3824533)
1. Sequential treatment with interferon and chemotherapy of metastatic malignant melanoma. Total remission of cutaneous and visceral metastasis, but not of cerebral metastasis.
Sulis E; Floris C; Chessa A; Desogus A; Muggiano A; Tedde A; Turno R
Tumori; 1987 Feb; 73(1):55-8. PubMed ID: 3824533
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
Vuoristo MS; Hahka-Kemppinen M; Parvinen LM; Pyrhönen S; Seppä H; Korpela M; Kellokumpu-Lehtinen P
Melanoma Res; 2005 Aug; 15(4):291-6. PubMed ID: 16034308
[TBL] [Abstract][Full Text] [Related]
3. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
[TBL] [Abstract][Full Text] [Related]
4. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH
Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931
[TBL] [Abstract][Full Text] [Related]
5. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
6. Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy.
Hahka-Kemppinen M; Muhonen T; Virolainen M; Jekunen A; Asko-Seljavaara S; Pyrhönen S
Br J Dermatol; 1995 Jun; 132(6):973-7. PubMed ID: 7544996
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients.
Ron IG; Inbar MJ; Gutman M; Merimsky O; Chaitchik S
Cancer Immunol Immunother; 1993 Jul; 37(1):61-6. PubMed ID: 8513453
[TBL] [Abstract][Full Text] [Related]
8. [Systemic therapy of metastatic malignant melanoma].
Stahel RA; Martz G
Schweiz Rundsch Med Prax; 1988 Apr; 77(17):459-62. PubMed ID: 3259710
[No Abstract] [Full Text] [Related]
9. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
Kivelä T; Suciu S; Hansson J; Kruit WH; Vuoristo MS; Kloke O; Gore M; Hahka-Kemppinen M; Parvinen LM; Kumpulainen E; Humblet Y; Pyrhönen S
Eur J Cancer; 2003 May; 39(8):1115-20. PubMed ID: 12736111
[TBL] [Abstract][Full Text] [Related]
10. Metastatic malignant melanoma treated with procarbazine, vincristine and lomustine (POC).
Repetto L; Grimaldi A; Ardizzoni A; Sertoli MR; Rosso R
Chemioterapia; 1987 Feb; 6(1):63-5. PubMed ID: 3829137
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
Rudolf Z; Plesnicar S
Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of malignant melanoma at the stage of distant metastasis].
Garbe C; Eigentler TK
Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
[TBL] [Abstract][Full Text] [Related]
13. BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
Nathan FE; Berd D; Sato T; Shield JA; Shields CL; De Potter P; Mastrangelo MJ
J Exp Clin Cancer Res; 1997 Jun; 16(2):201-8. PubMed ID: 9261748
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with dacarbazine and lomustine in disseminated malignant melanoma.
Joensuu H; Asola R; Minn H
Acta Radiol Oncol; 1986; 25(3):177-9. PubMed ID: 3020881
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.
Dillman RO; Soori G; Wiemann MC; Schulof R; Dobbs TW; Ruben RH; DePriest CB; Church C
Cancer Biother Radiopharm; 2000 Oct; 15(5):487-94. PubMed ID: 11155820
[TBL] [Abstract][Full Text] [Related]
17. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T
J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
[TBL] [Abstract][Full Text] [Related]
18. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
Reinhold U; Bruske T; Kreysel HW
Eur J Cancer; 1996 Jan; 32A(1):180. PubMed ID: 8695233
[No Abstract] [Full Text] [Related]
19. Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma.
Vuoristo MS
Melanoma Res; 1996 Aug; 6(4):331-6. PubMed ID: 8873054
[TBL] [Abstract][Full Text] [Related]
20. Systemic chemotherapy in the treatment of malignant melanoma.
Lens MB; Eisen TG
Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]